Table: AFC-HD Ams Life Science -2022/23 group results

AFC-HD AMS Life Science

13/10/2023 07:00

Oct 13 (Reuters)- 
          AFC-HD Ams Life Science Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Aug 31, 2023    Aug 31, 2022   Aug 31, 2024     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales             25.58           23.02          28.46        13.76    
                 (+11.1 pct)                    (+11.2 pct)  (+10.6 pct) 
  Operating          1.64            1.02           1.80       771 mln   
                 (+61.2 pct)                    (+10.1 pct)  (+13.8 pct) 
  Recurring          1.65            1.34           1.79       763 mln   
                 (+23.1 pct)                    (+8.1 pct)    (+7.9 pct) 
  Net
  Net                1.08          735 mln          1.12       471 mln   
                 (+47.3 pct)                    (+3.7 pct)   (+14.0 pct) 
  EPS             77.14 yen       52.33 yen      80.42 yen    33.78 yen  
  EPS Diluted     77.09 yen       52.08 yen                              
  Ann Div         27.50 yen       30.00 yen      30.00 yen               
  -Q2 Div         12.50 yen       15.00 yen      15.00 yen               
  -Q4 Div         15.00 yen       15.00 yen      15.00 yen               
  
  NOTE - AFC-HD Ams Life Science Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2927.T